Men and patients diagnosed with cystic fibrosis (CF) earlier in life have higher lung function and greater lung function…
Articles by Patricia Inácio, PhD
Destiny Pharma is launching a research program to test a potential therapy derived from its XF drug platform…
Combining telehealth with home spirometry to assess lung function, along with some in-person visits to the doctor’s office, was as…
Trikafta (elexacaftor/tezacaftor/ivacaftor) significantly lowered several pro-inflammatory blood markers with as early as one month of use in cystic…
Vertex Pharmaceuticals and England’s National Health Service (NHS) have reached an agreement that allows all current and future eligible…
Most parents of newborns diagnosed with cystic fibrosis (CF) or a different disease as part of U.S.
The use of the approved medication Trikafta (elexacaftor/tezacaftor/ivacaftor) was shown to significantly increase weight in people with cystic fibrosis-related…
The European Commission has granted orphan drug designation to ARCT-032, an inhaled experimental treatment for cystic fibrosis (CF) developed by…
People with cystic fibrosis (CF) can have abnormal levels or metabolism of three “essential nutrients” — vitamin D, calcium,…
Up to almost 30% of teenagers and adults with cystic fibrosis (CF) in the U.S. have…